The United States spends $5.3 trillion on healthcare annually, about $15,474 per person, consuming 18% of the entire economy. No other wealthy nation comes close. The short answer to why is deceptively simple: Americans don’t use more healthcare than people in other countries. They just pay dramatically more for the same things.
It’s the Prices, Not the Volume
The most persistent myth about U.S. healthcare spending is that Americans overuse medical services. The data says otherwise. Compared to other wealthy nations, the U.S. has similar or lower rates of hospital stays, doctor visits, and days spent in the hospital. For common procedures like hip replacements, knee replacements, CT scans, and cataract surgeries, American usage is average or only slightly above. Overall utilization looks, as one researcher put it, “pretty average.”
What isn’t average is the price tag attached to each service. A CT scan of the abdomen costs $553 through a private insurance plan in the U.S., compared to $260 in Australia or $76 through Canada’s public system. An MRI of a knee joint runs $566 on private insurance here versus $325 in Australia or $49 in Canada. Interestingly, Medicare (the government program for older Americans) pays only slightly more than public systems abroad for these same scans. The real markup happens in the private insurance market, where prices are negotiated between hospitals and insurers with little transparency.
Brand-Name Drugs Cost Three to Four Times More
Prescription drug pricing is one of the starkest differences between the U.S. and the rest of the world. Brand-name drug prices in America run 422% of what other high-income countries pay for the same medications. Even after adjusting for the rebates that drug manufacturers quietly pay back to insurers and pharmacy benefit managers, U.S. prices are still 308% of international levels.
Most other wealthy countries negotiate drug prices at a national level or set price ceilings. The U.S. has historically left pricing largely to the market, giving pharmaceutical companies significant leverage. A drug that costs $100 in Germany or France can easily cost $300 to $400 here for the identical product.
Doctors and Specialists Earn Far More
Physician compensation is another major driver. Research comparing the U.S. to six European countries found that the main reason Americans spend more isn’t that doctors order more tests or that medical training costs more. It’s that U.S. physicians, particularly specialists like orthopedic surgeons, receive substantially higher fees for their services. A specialist in the U.S. can earn two to three times what a peer in Germany or the UK makes for comparable work. Primary care doctors also earn more, though the gap is narrower.
Administrative Costs Dwarf Other Countries
Running the American healthcare system requires an enormous bureaucracy. Administrative costs, meaning the money spent on planning, regulating, billing, and managing health systems, eat up about 8% of total healthcare spending in the U.S. In peer countries, that figure ranges from 1% to 3%.
The complexity comes from having thousands of private insurers, each with different coverage rules, billing codes, and prior authorization requirements. Hospitals employ large teams just to handle insurance paperwork. Doctors’ offices spend hours on the phone getting approval for treatments. Medicare, the public program, operates with administrative costs around 2% of its budget. Private insurers, by contrast, spend roughly 17% of revenue on administration, and that figure often excludes marketing costs and profits.
Hospital Consolidation Reduces Competition
Over the past decade, the U.S. healthcare market has rapidly consolidated. Hospitals have been buying up physician practices at a striking pace: at least 47% of physicians were part of hospital systems in 2024, up from less than 30% in 2012. Private equity firms and insurance companies have also been acquiring practices.
This matters because consolidation gives health systems more bargaining power over insurers, which translates directly into higher prices for patients. When a hospital system buys an independent doctor’s office, the same office visit can be billed at a higher “hospital-based” rate. Studies reviewed by the U.S. Government Accountability Office found that these mergers lead to increased spending for both Medicare and commercial insurance. In markets where one or two hospital systems dominate, there’s simply no competitive pressure to keep prices down.
Chronic Disease Drives 90% of Spending
The U.S. carries a heavy burden of chronic illness. Conditions like diabetes, heart disease, obesity, and mental health disorders account for 90% of the nation’s healthcare expenditures. That’s not unique to America (chronic diseases are expensive everywhere), but the U.S. has particularly high rates of obesity and diabetes compared to peer nations, which amplifies the cost problem.
Managing a chronic condition means years of medications, specialist visits, lab tests, and sometimes hospitalizations. When each of those individual services costs more than it does anywhere else in the world, the cumulative spending on chronic disease becomes enormous. Prevention and early intervention are cheaper than treatment, but the U.S. system is overwhelmingly oriented toward treating illness after it develops rather than preventing it.
Defensive Medicine Adds Billions
Fear of malpractice lawsuits pushes doctors to order tests and procedures they might not otherwise recommend. This practice, known as defensive medicine, costs an estimated $46 billion per year. One study of hospital medicine services found that about 13% of per-patient costs were defensive in nature, primarily through extra hospital days and redundant testing. That’s not the largest slice of the spending pie, but it’s a meaningful one, and it’s largely unique to the U.S. legal environment.
Where the Money Goes Next
Healthcare spending is projected to keep outpacing economic growth. By 2033, it’s expected to consume 20.3% of GDP, up from 18% today. That trajectory means healthcare will take a growing share of wages, government budgets, and household income every year. The spending grew 7.2% in 2024 alone.
The core problem remains structural. Each piece of the system, from drug pricing to physician fees to administrative overhead to market consolidation, independently pushes costs higher. Other countries control these factors through centralized negotiation, standardized billing, or regulated pricing. The U.S. relies more heavily on market forces in a sector where normal market dynamics (transparent prices, informed consumers choosing between competitors) largely don’t exist. Until that fundamental architecture changes, American healthcare will remain the most expensive in the world by a wide margin.